LONDON (Alliance News) - Specialist healthcare company BTG PLC said Thursday that the first patient in Sinapore has been treated with TheraSphere, a treatment for primary liver cancer and metastatic colorectal cancer.
"Today's announcement is an important milestone for this therapy and for BTG's geographic expansion in Asia. Singapore is the second Asian market where we have launched TheraSphere and we're proud to be providing a new treatment option for patients with liver cancer," said General Manager of BTG Asia James Glasgow in a statement.
In Singapore, TheraSphere is approved for primary liver cancer and liver cancer that has spread from another point of origin.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
